Cerebralaneurysms are focal dilations of cerebral arteries that are present in approximately 3-5% of the general population. New research shows that small molecule inhibitors targeting the platelet-driven CXCL7-CXCR1/2 inflammatory pathway can be used to prevent cerebralaneurysm formation and rupture. · Preventing the formation, growth, and rupture of cerebralaneurysms.
Arterial dilation in the brain results in a cerebralaneurysm at risk of rupture, which can result in catastrophic life-long consequences or death. Cerebralaneurysm. University of Pittsburgh researchers have developed new bioabsorbable metallic alloy coils coated with polyurethane based on fatty amide functional groups for treating various aneurysms.
One out of every 20 deaths in the United States is caused by stroke. If administered quickly, surgery or clot-dissolving agents can improve the odds of survival.